Simplify Asset Management Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1846368 Las Vegas, NV

Position in GILD

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$10,274,600

+$1,724,948 QoQ

Shares Held

81,325

+32.6% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

2.12%

of 13F equity value

Holder Rank

#426

of 2,266 holders

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Simplify Asset Management Inc. holds $101,858,817 across 8 Drug Manufacturers - General names. GILD ranks #5 (10.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVO	Novo Nordisk A S	504,918	$24,205,768
2	JNJ	Johnson & Johnson	72,879	$18,509,079
3	LLY	ELI LILLY & Co	14,715	$17,649,613
4	ABBV	AbbVie Inc.	64,461	$16,220,966
5	GILD	Gilead Sciences, Inc. This page	81,325	$10,274,600
6	AMGN	Amgen Inc	20,974	$7,595,104
7	AZN	Astrazeneca PLC	34,188	$6,482,728
8	MRK	Merck & Co., Inc.	7,167	$920,959

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,274,600	81,325	+32.6%	Shares	Sole	2026-07-16
2026-03-31	$8,549,652	61,345	+63.7%	Shares	Sole	2026-04-27
2025-12-31	$4,600,172	37,479	-37.7%	Shares	Sole	2026-02-09
2025-09-30	$6,680,646	60,186	+13.8%	Shares	Sole	2025-10-20
2025-06-30	$5,863,914	52,890	+148.6%	Shares	Sole	2025-08-07
2025-03-31	$2,383,527	21,272	-53.9%	Shares	Sole	2025-05-13
2024-12-31	$4,264,445	46,167	-52.0%	Shares	Sole	2025-02-11
2024-09-30	$8,065,575	96,202	+474.3%	Shares	Sole	2024-11-12
2023-12-31	$1,356,917	16,750	-6.8%	Shares	Sole	2024-02-12
2023-09-30	$1,346,971	17,974	+60.3%	Shares	Sole	2023-11-14
2023-06-30	$863,954	11,210	+32.9%	Shares	Sole	2023-08-14
2023-03-31	$700,100	8,438	+98.0%	Shares	Sole	2023-05-10
2022-12-31	$365,892	4,262	+8.8%	Shares	Sole	2023-02-10
2022-09-30	$241,763	3,919	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.